Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

BACKGROUND: The shift towards an earlier diagnosis of breast cancer (BC) highlights the need for biomarkers that would identify patients at risk for relapse and metastatic spread and indicate the potential value of additional treatment strategies. Osteopontin (OPN) is a matricellular protein that ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Psyrri, Amanda, Kalogeras, Konstantine T., Wirtz, Ralph M., Kouvatseas, George, Karayannopoulou, Georgia, Goussia, Anna, Zagouri, Flora, Veltrup, Elke, Timotheadou, Eleni, Gogas, Helen, Koutras, Angelos, Lazaridis, Georgios, Christodoulou, Christos, Pentheroudakis, George, Economopoulou, Panagiota, Laskarakis, Apostolos, Arapantoni-Dadioti, Petroula, Batistatou, Anna, Sotiropoulou, Maria, Aravantinos, Gerasimos, Papakostas, Pavlos, Kosmidis, Paris, Pectasides, Dimitrios, Fountzilas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304396/
https://www.ncbi.nlm.nih.gov/pubmed/28193231
http://dx.doi.org/10.1186/s12967-017-1134-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304396/
https://www.ncbi.nlm.nih.gov/pubmed/28193231
http://dx.doi.org/10.1186/s12967-017-1134-7

Ejemplares similares